This is a compilation of information regarding pancreatic cancer, its treatment, and recent advances.
Pancreatic cancer is an aggressive and ofen silent disease,frequently diagnosed at advanced stages due to a lack of early symptoms [[1]]. Only 20% of patients are candidates for surgery at diagnosis,40% have metastases,and the remaining 40% have locally advanced disease [[1]].
A new chemotherapy technique, isolated microperfusion, is being tested in Brazil, aiming to concentrate chemotherapy near the tumor and reduce side effects like fatigue, nausea, and hair loss [[1]]. Preliminary results suggest it may reduce side effects and improve quality of life [[1]]. This technique involves using a catheter with balloons to isolate the pancreatic circulation and deliver a concentrated dose of chemotherapy [[1]].
Research is also focused on improving screening methods,including genetic testing and artificial intelligence (AI) [[2]]. Additionally,robotic surgery,specifically the whipple procedure,is being used to improve treatment for localized pancreatic cancer [[3]].
The five-year survival rate for pancreatic cancer is only 10.8% [[1]].
